Dermectin™ Clinical Results
What is the evidence to prove Dermectin works?
During a six-month trial of several ingredients within the Dermacin Complex, the following results were achieved:
 |
A reduction in the appearance of wrinkles in terms of volume and depth |
 |
A reduction in the appearance of roughness and complexity (as surface "lifting" parameter) |
 |
A decrease in the area occupied by wrinkles, giving rise to a decrease in the appearance of density |
 |
Increase in skin-tone |

In a comparison of Dermectin's peptide-based ingredient vs placebo, significant results were achieved in the following areas:
Figure A (Study includes 59 women over a period of 56 days)

| Parameters |
Dermacin Complex with Peptides |
Placebo |
| Area occupied by wrinkles |
39.4% Decrease |
4.3% Increase |
| Wrinkle density |
32.6% Decrease |
9.6% Decrease |
| Roughness |
16.0% Decrease |
1.4% Increase |
| Complexity (measure of smoothness) |
15.7% Decrease |
4.2% Increase |
| Volume of wrinkles (main) |
23.3% Decrease |
8.7% Decrease |
| Avg. depth of wrinkles (main) |
19.9% Decrease |
3.2% Decrease |
Each measurement obtained identifies significant improvement in promoting healthy skin.
How soon are results achieved?
Clinical trials with the ingredients contained in the Dermacin Complex showed results in as little as two weeks, but more significant results at 1-2 months. See the figure below for a summary of the clinical results.
Figure B (Study results at 4 to 12 weeks)

What were some of the comments from the women tested during the trial?
In the clinical trials, women reported the following:
 |
"Made the skin smoother" |
 |
"Made the skin more supple" |
 |
"Reduced the appearance of wrinkles and lines" |
While these are subjective measurements, the comments demonstrate the utility of the Dermacin Complex on the skin and its effectiveness as a cosmetic application.
Learn more:
* Botox is a registered trademark of Allergan, Inc.
** StriVectin-SD is a registered trademark of Western Holdings LLC
|